Patent US4895151A successfully refreshed from Google Patents.
US4895151A
Expired / Lapsed
US
⏱️ 0.0 years remaining
Apparatus and method for therapy adjustment in implantable
Assignee: Pacesetter Inc
•
Filing: 1987-07-20
•
Granted: 1990-01-23
•
Expires: 2007-07-20
Abstract
Abstract Apparatus and method for treating tachyarrhythmias wherein the presence of a patient tachyarrhythmia is detected and a first antitachyarrhythmia therapy (antitachycardia pacing) is given at a first energy level. The haemodynamic condition of the patient is measured and a length of time to therapy switchover is continually derived during the application of the first antitachyarrhythmia therapy. The length of time to switchover is a function of the haemodynamic condition of the patient. When the time following detection of the patient tachyarrhythmia exceeds the length of time to switchover, a second antitachyarrhythmia therapy (a high energy shock) at a second energy level is provided. The average cardiac cycle length may be used as an indicator of the haemodynamic condition.
Inventors
- 👤 Richard Grevis
- 👤 Loraine Holley
Bibliographic Details
Application Number
—
Jurisdiction
US
Data Source
google_patents
Last Synchronized
2026-10-23 08:21
CPC Classifications
A; A61; A61N; A61N1/00; A61N1/18; A61N1/32; A61N1/36; A61N1/362; A61N1/3621; A61N1/365; A61N1/36514; A61N1/38; A61N1/39; A61N1/3956
Claims Analysis
Total Claims: 23
Claim 1
Independent Claim
108 words
A method of treating tachyarrhythmias first comprising the steps of detecting the presence of a patient tachyarrhythmia, applying anti-tachyarrhythmia pacing therapy to the patient responsive to detection of the presence of a tachyarrhythmia, measuring the haemodynamic condition of the patient and deriving continually a derived length of time to switchover which is a function of said haemodynamic condition while said anti-tachyarrhythmia pacing therapy is continued, and immediately switching over to applying cardioversion shock therapy instead of anti-tachyarrhythmia pacing therapy after an elapsed time following the first detection of the presence of a patient tachyarrhythmia as soon as said elapsed time exceeds said derived length of time to switchover.
Claim 2
Independent Claim
108 words
A method of treating tachyarrhythmias first comprising the steps of detecting the presence of a patient tachyarrhythmia, applying anti-tachyarrhythmia pacing therapy to the patient responsive to detection of the presence of a tachyarrhythmia, measuring the haemodynamic condition of the patient and deriving continually a derived length of time to switchover which is a function of said haemodynamic condition while said anti-tachyarrhythmia pacing therapy is continued, and immediately switching over to applying cardioversion shock therapy instead of anti-tachyarrhythmia pacing therapy after an elapsed time following the first detection of the presence of a patient tachyarrhythmia as soon as said elapsed time exceeds said derived length of time to switchover.
Claim 3
Dependent Claim
27 words
A method of treating tachyarrhythmias in accordance with claim 1 wherein the step of measuring the haemodynamic condition of the patient includes sensing average cardiac cycle length.
Claim 4
Dependent Claim
29 words
A method of treating tachyarrhythmias in accordance with claim 2 further comprising controlling said length of time to switchover to be a generally increasing function of cardiac cycle length.
Claim 5
Dependent Claim
24 words
A method of treating tachyarrhythmias in accordance with claim 3 further comprising controlling said length of time to switchover to have a maximum value.
Claim 6
Dependent Claim
64 words
A method of treating tachyarrhythmias in accordance with claim 2 further comprising said length of time to switchover to be a linear function of cardiac cycle length between a minimum time to switchover at a first cardiac cycle length and a maximum time to switchover at a second cardiac cycle length, said second cardiac cycle length being greater than said first cardiac cycle length.
Claim 7
Dependent Claim
24 words
A method of treating tachyarrhythmias in accordance with claim 1 further comprising controlling said length of time to switchover to have a maximum value.
Claim 8
Independent Claim
118 words
A method of treating tachyarrhythmias first comprising the steps of detecting the presence of a patient tachyarrhythmia, applying to the patient a first anti-tachyarrhythmia therapy of a first energy level responsive to detection of the presence of a tachyarrhythmia, measuring the haemodynamic condition of the patient and continually deriving a derived length of time to switchover which is a function of said haemodynamic condition while said first antitachyarrhythmia therapy is continued, and immediately switching over to applying to the patient a second anti-tachyarrhythmia therapy at a second energy level after an elapsed time following the first detection of the presence of a patient tachyarrhythimia as soon as said elapsed time exceeds said derived length of time to switchover.
Claim 9
Independent Claim
118 words
A method of treating tachyarrhythmias first comprising the steps of detecting the presence of a patient tachyarrhythmia, applying to the patient a first anti-tachyarrhythmia therapy of a first energy level responsive to detection of the presence of a tachyarrhythmia, measuring the haemodynamic condition of the patient and continually deriving a derived length of time to switchover which is a function of said haemodynamic condition while said first antitachyarrhythmia therapy is continued, and immediately switching over to applying to the patient a second anti-tachyarrhythmia therapy at a second energy level after an elapsed time following the first detection of the presence of a patient tachyarrhythimia as soon as said elapsed time exceeds said derived length of time to switchover.
Claim 10
Dependent Claim
27 words
A method of treating tachyarrhythmias in accordance with claim 7 wherein the step of measuring the haemodynamic condition of the patient includes sensing average cardiac cycle length.
Claim 11
Dependent Claim
29 words
A method of treating tachyarrhythmias in accordance with claim 8 further comprising controlling said length of time to switchover to be a generally increasing function of cardiac cycle length.
Claim 12
Dependent Claim
24 words
A method of treating tachyarrhythmias in accordance with claim 9 further comprising controlling said length of time to switchover to have a maximum value.
Claim 13
Dependent Claim
65 words
A method of treating tachyarrhythmias in accordance with claim 8 further comprising controlling said length of time to switchover to be a linear function of cardiac cycle length between a minimum time to switchover at a first cardiac cycle length and a maximum time to switchover at a second cardiac cycle length, said second cardiac cycle length being greater than said first cardiac cycle length.
Claim 14
Dependent Claim
24 words
A method of treating tachyarrhythmias in accordance with claim 7 further comprising controlling said length of time to switchover to have a maximum value.
Claim 15
Dependent Claim
146 words
A medical device for treating tachyarrhythmias comprising means for detecting the presence of a patient tachyarrhythmia, first means responsive to said detecting means for first applying to the patient a first anti-tachyarrhythmia therapy at a first energy level, measuring and deriving means for measuring the haemodynamic condition of the patient and continually deriving during said first antitachyarrhythmia therapy a length of time to switchover during which said first antitachyarrhythmia therapy continues, said length of time being a function of said haemodynamic condition as measured by said measuring and deriving means, second means for applying to the patient a second antitachyarrhythmia therapy at a second energy level, and switchover means for causing an immediate switchover from the operation of said first means to the operation of said second means as soon as the time following operation of said detecting means exceeds said length of time until switchover.
Claim 16
Dependent Claim
146 words
A medical device for treating tachyarrhythmias comprising means for detecting the presence of a patient tachyarrhythmia, first means responsive to said detecting means for first applying to the patient a first anti-tachyarrhythmia therapy at a first energy level, measuring and deriving means for measuring the haemodynamic condition of the patient and continually deriving during said first antitachyarrhythmia therapy a length of time to switchover during which said first antitachyarrhythmia therapy continues, said length of time being a function of said haemodynamic condition as measured by said measuring and deriving means, second means for applying to the patient a second antitachyarrhythmia therapy at a second energy level, and switchover means for causing an immediate switchover from the operation of said first means to the operation of said second means as soon as the time following operation of said detecting means exceeds said length of time until switchover.
Claim 17
Dependent Claim
26 words
A medical device for treating tachyarrhythmias in accordance with claim 13 wherein said measuring and deriving means includes sensing means, for sensing average cardiac cycle length.
Claim 18
Dependent Claim
66 words
A medical device for treating tachyarrhythmias in accordance with claim 14 wherein said switchover means includes a control means and said measuring and deriving means provides an input to said control means, said input being responsive to said sensed cardiac cycle length, so that said control means controls the length of time to switchover to be a generally increasing function of the sensed cardiac cycle length.
Claim 19
Dependent Claim
58 words
A medical device for treating tachyarrhythmias in accordance with claim 15 wherein said measuring and deriving means includes a converting means for converting the sensed average cardiac cycle length to said length of time to switchover, said converting means providing said input to said control means so that the length of time to switchover has a maximum value.
Claim 20
Dependent Claim
99 words
A medical device for treating tachyarrhythmias in accordance with claim 14 wherein said measuring and deriving means includes a converting means for converting the sensed average cardiac cycle length to said length of time to switchover, said converting means providing said input to said control means so that the length of time to switchover is a linear function of cardiac cycle length between a minimum time to switchover at a first cardiac cycle length and a maximum time to switchover at a second cardiac cycle length, said second cardiac cycle length being greater than said first cardiac cycle length.
Claim 21
Dependent Claim
46 words
A medical device for treating tachyarrhythmias in accordance with claim 13 wherein said switchover means includes a control means and said measuring and deriving means provides an input to said control means so that said control means controls the switch-over time to have a maximum value.
Claim 22
Dependent Claim
49 words
The method of claim 5 further comprising controlling said length of time to switchover to be a constant when said cardiac cycle length varies between said second cardiac cycle length and a third cardiac cycle length, said third cardiac cycle length being greater than said second cardiac cycle length.
Claim 23
Dependent Claim
88 words
A medical device for treating tachyarrhythmias in accordance with claim 17 wherein said measuring and deriving means includes a converting means for converting the sensed average cardiac cycle length to said length of time to switchover, said converting means providing said input to said control means so that said length of time to switchover is a constant when said cardiac cycle length varies between said second cardiac cycle length and a third cardiac cycle length, said third cardiac cycle length being greater than said second cardiac cycle length.
References Cited (Backward Citations)
US4307725A
Cited
US4375817A
Cited
US4407288A
Cited
US4407288B1
Cited
US4384585A
Cited
US4750494A
Cited
US4473078A
Cited
US4712556A
Cited
US4548209A
Cited
US4712555A
Cited
US4830006A
Cited
US4830006B1
Cited
US4750495A
Cited
USPTO Annuity & Maintenance Windows
| Annuity Stage | Window Opens | Payment Deadline | Surcharge Period Until | Estimated Fee | Status |
|---|---|---|---|---|---|
| 3.5 Years (Year 4) | 1993-01-22 | 1993-07-24 | 1994-01-23 | $2000.00 | Window Closed / Lapsed |
| 7.5 Years (Year 8) | 1997-01-22 | 1997-07-24 | 1998-01-23 | $3760.00 | Window Closed / Lapsed |
| 11.5 Years (Year 12) | 2001-01-22 | 2001-07-24 | 2002-01-23 | $7700.00 | Window Closed / Lapsed |